Skip to main content
C

CairnSurgical

CairnSurgical is developing the Breast Cancer Locator™ System (BCL™), a patient-specific, 3D-printed surgical guidance tool that provides precise localization of breast tumors during surgery. This technology addresses the high re-excision rates associated with traditional tumor localization methods by offering a detailed 3D visualization of tumor characteristics in the supine position, thereby improving surgical outcomes and preserving healthy tissue.

Lebanon, United StatesFounded 201714500+ followers
Updated 20 months ago

Funding

$23.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

MV
Funding rounds are not available yet.

Founders

Product

Problem

Current breast-conserving surgical techniques often result in re-excision rates exceeding 20% due to imprecise tumor localization. Traditional methods, such as wire or seed localization, can be invasive, inconvenient, and may not accurately represent the tumor's characteristics in the supine position during surgery. This can lead to the removal of excessive healthy tissue to ensure clear margins, impacting cosmetic outcomes.

Solution

CairnSurgical's Breast Cancer Locator™ System (BCL™) addresses these challenges by providing surgeons with a patient-specific, 3D-printed surgical guide for precise tumor localization. The BCL™ system utilizes pre-operative breast MRI data to create a detailed 3D visualization of the tumor's location, size, shape, depth, and edges in the supine position, the same position as the patient on the operating table. This 3D visualization is delivered through the Visualizer™ software. By offering a blueprint of the tumor and a surgical guide, the BCL™ System aims to reduce or eliminate guesswork during surgery, increasing precision and improving the likelihood of achieving clear margins in a single procedure.

Target Audience

The primary target audience includes breast surgeons and hospitals seeking to improve the precision and outcomes of breast-conserving surgeries.

Features

  • Patient-specific 3D-printed surgical guide based on pre-operative MRI data.
  • Interactive 3D visualization of the tumor in the supine position using the Visualizer™ software.
  • Provides a detailed blueprint of the tumor's location, size, shape, depth, and edges.
  • Designed to improve surgical precision and reduce re-excision rates.
  • Aims to minimize the removal of healthy breast tissue.
This profile is AI-generated and may contain inaccuracies.